WeirFoulds represents Antibe Therapeutics Inc. in completion of $5.75-million bought deal public offering
On February 27, 2019, Antibe Therapeutics Inc. (TSXV: ATE, OTCQB: ATBPF) announced that it closed its previously announced bought deal public offering of 23,000,000 units of the…